The Safety and Efficacy of Supraglottic Airway Use in Children
27 juli 2015 uppdaterad av: Narasimhan Jagannathan, Ann & Robert H Lurie Children's Hospital of Chicago
This purpose of this study is to determine the effectiveness, risk factors, and complications associated with use of supraglottic airway devices for primary airway maintenance during routine anesthesia in children.
Studieöversikt
Status
Okänd
Betingelser
Intervention / Behandling
Detaljerad beskrivning
This study aims to understand the efficacy of supraglottic airway (SGA) use in children in a tertiary care Children's Hospital.
Observational data regarding the type of SGA, experience level of practitioner, placement technique, number of placement attempts or placement failure, device failure, and cause of any related peri-operative complications will be prospectively collected.
The data collected in this study will allow the investigators to assess the overall safety and efficacy of SGA use in various medical and surgical procedures performed under general anesthesia in children.
Studietyp
Observationell
Inskrivning (Förväntat)
10000
Kontakter och platser
Det här avsnittet innehåller kontaktuppgifter för dem som genomför studien och information om var denna studie genomförs.
Studieorter
-
-
Illinois
-
Chicago, Illinois, Förenta staterna, 60611
- Rekrytering
- Ann & Robert H. Lurie Children's Hospital of Chicago
-
Kontakt:
- Narasimhan Jagannathan, MD
- E-post: simjag2000@yahoo.com
-
Huvudutredare:
- Narasimhan Jagannathan, MD
-
-
Deltagandekriterier
Forskare letar efter personer som passar en viss beskrivning, så kallade behörighetskriterier. Några exempel på dessa kriterier är en persons allmänna hälsotillstånd eller tidigare behandlingar.
Urvalskriterier
Åldrar som är berättigade till studier
1 dag till 18 år (Barn, Vuxen)
Tar emot friska volontärer
Ja
Kön som är behöriga för studier
Allt
Testmetod
Icke-sannolikhetsprov
Studera befolkning
Pediatric patients undergoing anesthesia with use of a supraglottic airway device as primary means of oxygenation and ventilation.
Beskrivning
Inclusion Criteria:
- Children undergoing anesthesia with use of a supraglottic airway device as a primary means of oxygenation & ventilation
Exclusion Criteria:
- N/A
Studieplan
Det här avsnittet ger detaljer om studieplanen, inklusive hur studien är utformad och vad studien mäter.
Hur är studien utformad?
Designdetaljer
Kohorter och interventioner
Grupp / Kohort |
Intervention / Behandling |
|---|---|
|
Supraglottic Airway Device
Patients will receive a supraglottic airway device as a primary means of ventilation.
The following devices may be used: LMA Unique, LMA ProSeal, LMA Supreme, LMA Flexible, Ambu Aura-I, Ambu Aura Once, Air-Q, I-Gel, or other supraglottic airway device.
Choice of the device will be clinician dependent and based on the patients body weight per manufacturer guidelines
|
Andra namn:
|
Vad mäter studien?
Primära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Supraglottic Airway Device Failure
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
Occurrence and reason for supraglottic airway device failure (ie inadequate ventilation, laryngospasm, bronchospasm, etc) will be recorded in addition to conversion to tracheal intubation
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
Sekundära resultatmått
Resultatmått |
Åtgärdsbeskrivning |
Tidsram |
|---|---|---|
|
Ease of Placement of Supraglottic Airway Device
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
Ease of placement of supraglottic airway device ranging from 1 (easy) to 4 (difficult)
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
|
Multiple Attempts to Place Supraglottic Airway Device
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
change in device, placement method, and provider will be recorded
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
|
Airway Maneuvers/interventions
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
the number and type of airway maneuvers performed after device placement and during maintenance will be recorded
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
|
Occurrence of Inadequate Ventilation
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
cause and solution for inadequate ventilation will be recorded
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
|
Intraoperative Complications
Tidsram: participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
Time period of complication (ie during device placement, maintenance, or removal) and cause of complication (ie.
dental injury, light anesthesia, regurgitation, laryngospasm, bronchospasm, aspiration, etc.) will be recorded
|
participants will be followed for the duration of anesthesia and after surgery, an expected average of 12 hours
|
|
Postoperative Complications
Tidsram: participants will be followed for the duration of anesthesia and 24 hours postoperatively
|
Complications noted postoperatively relating to reflex activation of the airway, sore throat, or hoarseness
|
participants will be followed for the duration of anesthesia and 24 hours postoperatively
|
Samarbetspartners och utredare
Det är här du hittar personer och organisationer som är involverade i denna studie.
Utredare
- Huvudutredare: Narasimhan Jagannathan, MD, Ann & Robert H. Lurie Children's Hospital of Chicago / Stanley Manne Research Institute
Publikationer och användbara länkar
Den som ansvarar för att lägga in information om studien tillhandahåller frivilligt dessa publikationer. Dessa kan handla om allt som har med studien att göra.
Allmänna publikationer
- Lopez-Gil M, Brimacombe J, Alvarez M. Safety and efficacy of the laryngeal mask airway. A prospective survey of 1400 children. Anaesthesia. 1996 Oct;51(10):969-72. doi: 10.1111/j.1365-2044.1996.tb14968.x.
- Mathis MR, Haydar B, Taylor EL, Morris M, Malviya SV, Christensen RE, Ramachandran SK, Kheterpal S. Failure of the Laryngeal Mask Airway Unique and Classic in the pediatric surgical patient: a study of clinical predictors and outcomes. Anesthesiology. 2013 Dec;119(6):1284-95. doi: 10.1097/ALN.0000000000000015.
- Jagannathan N, Sequera-Ramos L, Sohn L, Wallis B, Shertzer A, Schaldenbrand K. Elective use of supraglottic airway devices for primary airway management in children with difficult airways. Br J Anaesth. 2014 Apr;112(4):742-8. doi: 10.1093/bja/aet411. Epub 2013 Dec 8.
- Asai T. Is it safe to use supraglottic airway in children with difficult airways? Br J Anaesth. 2014 Apr;112(4):620-2. doi: 10.1093/bja/aeu005. Epub 2014 Feb 20. No abstract available.
- Bordet F, Allaouchiche B, Lansiaux S, Combet S, Pouyau A, Taylor P, Bonnard C, Chassard D. Risk factors for airway complications during general anaesthesia in paediatric patients. Paediatr Anaesth. 2002 Nov;12(9):762-9. doi: 10.1046/j.1460-9592.2002.00987.x.
- Lalwani K, Richins S, Aliason I, Milczuk H, Fu R. The laryngeal mask airway for pediatric adenotonsillectomy: predictors of failure and complications. Int J Pediatr Otorhinolaryngol. 2013 Jan;77(1):25-8. doi: 10.1016/j.ijporl.2012.09.021. Epub 2012 Oct 11.
Studieavstämningsdatum
Dessa datum spårar framstegen för inlämningar av studieposter och sammanfattande resultat till ClinicalTrials.gov. Studieposter och rapporterade resultat granskas av National Library of Medicine (NLM) för att säkerställa att de uppfyller specifika kvalitetskontrollstandarder innan de publiceras på den offentliga webbplatsen.
Studera stora datum
Studiestart
1 juni 2014
Primärt slutförande (Förväntat)
1 oktober 2015
Avslutad studie (Förväntat)
1 oktober 2015
Studieregistreringsdatum
Först inskickad
25 juli 2014
Först inskickad som uppfyllde QC-kriterierna
25 juli 2014
Första postat (Uppskatta)
28 juli 2014
Uppdateringar av studier
Senaste uppdatering publicerad (Uppskatta)
29 juli 2015
Senaste inskickade uppdateringen som uppfyllde QC-kriterierna
27 juli 2015
Senast verifierad
1 juli 2015
Mer information
Termer relaterade till denna studie
Nyckelord
Andra studie-ID-nummer
- 2014-15832
Denna information hämtades direkt från webbplatsen clinicaltrials.gov utan några ändringar. Om du har några önskemål om att ändra, ta bort eller uppdatera dina studieuppgifter, vänligen kontakta register@clinicaltrials.gov. Så snart en ändring har implementerats på clinicaltrials.gov, kommer denna att uppdateras automatiskt även på vår webbplats .